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Abstract 
FoxO transcription factors play important roles in many cellular processes, including regulation 
of lifespan in invertebrates and potentially in vertebrates.  Our understanding of FoxO target 
genes that play a role in lifespan control is incomplete and C. elegans is a useful system in which 
to approach this problem since it has a single FoxO ortholog (DAF-16) and a relatively short 
lifespan.  Using multiple unique genetic filters and RNA-sequencing, we have previously 
identified a list of 47 putative daf-16/FoxO target genes that are likely to play a role in lifespan 
extension.  Y39G8B.7  is one of these genes and showed a significant shortening of lifespan in a 
long-lived background during a pilot lifespan assay.  I have validated Y39G8B.7 as a bona fide 
daf-16/FoxO target gene and investigated its functional role in longevity.        
 
Introduction 
Forkhead box, class O (FoxO) transcription factors (TFs) are a group of proteins that play a 
complex role in development, longevity, and homeostatic maintenance in a wide variety of 
species (Arden, 2008).  In the context of aging, FoxO TFs promote lifespan extension in 
numerous organisms, and their misregulation may be of importance in age associated diseases in 
humans, such as cancer, type II diabetes, and osteoporosis (Arden, 2008; van der Horst & 
Burgering, 2007).  Furthermore, genetic variation in the FOXO3A gene in humans is associated 
with extreme longevity and healthy aging (Willcox et al., 2008).  Despite the important role they 
play in aging, the group of FoxO target genes that mediate this process is poorly defined and 
requires more investigation.    
Our current understanding of the regulation and effects of FoxO factors has been largely 
elucidated using the nematode Caenorhabditis elegans and fruit fly Drosophila melanogaster 
model systems.  It was in C. elegans that a forward genetic screen first implicated a FoxO 
ortholog, daf-16, as an important independent phenotypic mediator.  The study demonstrated that 
DAF-16/FoxO played a critical role in formation of dauer larvae (Swanson & Riddle, 1981).  
Dauer is a reversible developmental arrest stage that can be induced by stressful environmental 
conditions such as overcrowding, lack of food, or elevated temperature.  Various genetic screens 
utilized this developmental feature to identify modifiers of the dauer phenotype, a few of which 
would be found to be the foundation of an insulin-like signaling pathway in C. elegans that 
regulates the activity of DAF-16/FoxO.  The C. elegans  insulin receptor, daf-2/InsR and daf-23, 
which would later be identified as age-1 (PI3K), were isolated as genes whose mutation caused 
constitutive dauer arrest (Gottlieb & Ruvkun, 1994; Vowels & Thomas, 1992).  On the other 
hand, daf-16/FoxO was identified as a gene that, when mutated, caused defective dauer 
formation in normally constitutive strains (Gottlieb & Ruvkun, 1994; Vowels & Thomas, 1992).  
The data from these dauer screens suggested a pathway in which daf-2/InsR, daf-23, and daf-
18/PTEN interact to regulate the function of daf-16/FoxO. 
In addition to being implicated in the process of dauer formation, daf-16/FoxO and other 
components of the insulin/insulin-like growth factor signaling (IIS) pathway that regulate it were 
found to play a significant role in longevity of C. elegans.  age-1/PI3K was the first long-lived 
single mutant identified (Friedman & Thomas, 1987; Klass, 1983), and individual mutation of 
daf-2/InsR was later found to nearly double lifespan of worms (Kenyon, 1993).  These large 
extensions were both found to be dependent on the proper function of DAF-16/FoxO, as a single 
additional mutation in daf-16/FoxO in both the age-1/PI3K and daf-2/InsR backgrounds 
suppressed the long-lived phenotypes (Kenyon, 1993; Murakami & Johnson, 1996).  Beyond its 
requirement for IIS lifespan extension, daf-16/FoxO was also found to be required for longevity 
induced by IIS independent process of germline stem cell ablation (Hsin & Kenyon, 1999).   The 
regulation of DAF-16/FoxO is still an active area of research today, but the transcription factor's 
importance in C.elegans stress resistance and longevity, as well as its conservation in a wide 
variety of species spurred further investigation in other model organisms.   
In D. melanogaster, the well-conserved DAF-16 homolog, dFoxO appears to play a role that is 
very similar to its C. elegans counterpart.  dFoxO overexpression causes a phenotype similar to 
starvation that can be rescued by co-expression of upstream IIS components, suggesting a 
nutrient sensing role not unlike that of DAF-16 in the dauer decision of worms (Kramer, 
Davidge, Lockyer, & Staveley, 2003).  Flies that are lack dFoxO are viable, but are more 
sensitive to oxidative stress (Jünger et al., 2003).  Furthermore, dFoxO expression in the fly 
pericerebral fat body leads to a large extension of lifespan that is mediated through the conserved 
components of the IIS pathway (Hwangbo, Gersham, Tu, & Palmer, 2004).  Like in C. elegans, 
the DAF-16 ortholog in D. melanogaster promotes lifespan extension and increased stress 
resistance.     
Due to the critical role that FoxO transcription factors play in worms and flies, as well as the 
highly conserved nature of the IIS pathway that regulates them, deciphering the biology of 
mammalian FoxOs has been of great interest.  In mammals, the FoxO subfamily has four known 
members - FoxO1, 3, 4, and 6.  All four share a DNA-binding domain that binds to the same 
consensus motif as DAF-16/FoxO and are regulated by conserved components of the IIS 
pathway (Furuyama, Nakazawa, Nakano, & Mori, 2000).  The FoxO proteins have been 
implicated as potential and confirmed players in mammalian aging and age-associated diseases.     
FoxO1 and FoxO6 both appear to be involved in the development and progression of diabetes in 
the Mus musculus model system.  FoxO1, acts as a negative regulator of insulin sensitivity 
through its control of β-cell proliferation (Kitamura et al., 2002; Nakae et al., 2002).  Impaired 
insulin suppression leads to abnormally high levels of FoxO6 in the liver, which serve as a 
causative factor for uninhibited gluconeogenesis.  This increase in circulating glucose leads to 
fasting hyperglycemia in morbid obesity and type II diabetes (Dae Hyun Kim, Zhang, Lee, & 
Dong, 2013).  FoxO3 does not appear to play a direct role in mammalian diabetes, but it is 
involved in diabetic nephropathy and renal disease (Kato et al., 2006).        
In addition to diabetes, FoxOs have been implicated in two other age-associated diseases as well: 
osteoporosis and cancer.  FoxO1, 3, and 4 are expressed at similar levels in bones and bone cells 
and play important roles in the maintenance of bone homeostasis, which goes awry during 
osteoporosis.  Namely, FoxOs regulate both osteoblastogenesis and osteoclastogenesis through 
both direct and indirect mechanisms (Almeida, 2011).  In the context of cancer, FoxOs have been 
shown to be tumor suppressors (Paik et al., 2007) and to be involved in a complex interplay with 
p53 to regulate disease and aging (van der Horst & Burgering, 2007).   
The importance of DAF-16, IIS, and their fly counterparts in longevity and healthy aging of their 
respective organisms is irrefutable, and more data is emerging that suggests a similar role for 
mammalian FoxOs.  Studying the role of these transcription factors is more difficult in murine 
models, as null mutations in IIS components like FoxO1 and insulin-like growth factor type I 
receptor (IGF-1R) are lethal.  However, mice that are heterozygous for Igf1r have been shown to 
live significantly longer than their litter-mates and have increased resistance to oxidative stress 
(Holzenberger et al., 2003).  Additionally, unlike FoxO1 nulls, FoxO3 null mice are viable, but 
show age-dependent infertility, accelerated ovarian follicular development and ultimate follicular 
depletion that may be similar to the premature ovarian failure that is a common cause of human 
premature aging in women (Castrillon, Miao, Kollipara, Horner, & DePinho, 2003).  In humans 
genetic variation in the FOXO3A gene is strongly associated with longevity and healthy aging 
(Willcox et al., 2008).  It is clear that FoxO transcription factors play a definitive or likely role in 
the pathobiology of a host of complex, diverse age-associated diseases, as well as longevity 
itself.  Deciphering the regulation and mechanisms of action of these proteins should prove to be 
important for understanding these processes.   
Despite the plethora of research on FoxOs, our knowledge of their transcriptional targets that are 
involved in lifespan extension is incomplete.  In C. elegans, various microarray studies have 
been performed with the intent of identifying DAF-16/FoxO target genes involved in longevity.  
Surprisingly, there is relatively low overlap between the resulting gene sets (McCormick, Chen, 
Ramaswamy, & Kenyon, 2012; McElwee, Schuster, Blanc, Thomas, & Gems, 2004; Murphy, 
2006).  This low agreement makes it difficult to prioritize putative targets for functional testing, 
and as a result, proper evaluation of these potential target genes' role in lifespan extension is 
lacking.   
Our lab addressed this problem using multiple genetic filters and RNA-sequencing (RNA-seq) to 
vet target genes for ones specifically involved in lifespan.  The first filter took advantage of the 
fact that the daf-16/FoxO locus produces multiple protein isoforms, but only two of them, DAF-
16A and F promote lifespan extension (Kwon & Narasimhan, 2011).  Additionally, an isoform-
specific mutant, (mg54), introduces stop codons into the A and F coding regions and suppresses 
extension to the same degree as daf-16(mu86) null mutation (unpublished).  Therefore, in the 
contexts of longevity induced by reduced insulin signaling and germline ablation, genes whose 
expression levels are changed by both mg54 or mu86 mutation are likely to be specifically 
regulated by DAF-16A or F and involved in lifespan extension.   
The second filter involved looking for genes whose expression levels were altered in three 
different long-lived backgrounds in a daf-16/FoxO dependent manner.  Gene expression levels 
were determined using RNA-seq, which has several advantages over traditional microarray 
technology.  Namely, RNA-seq provides more accurate transcriptome information through better 
dynamic expression range and its improved ability to discern between isoforms and alleles 
(Wang, Gerstein, & Snyder, 2009).  Two long-lived mutant daf-2/InsR alleles were used, daf-
2(e1368) and daf-2(e1370), as well as a long-lived germline ablation mutant, glp-1(e2141).  
Whole transcriptome RNA-seq expression levels for the two daf-2 backgrounds were compared 
to WT, mg54;daf-2, and mu86;daf-2.  The glp-1 background expression levels were also 
compared to mg54;glp-1 and mu86;glp-1, but lacked the direct WT comparison due to large 
transcriptome size differences associated with germline ablation.  By looking for genes whose 
expression levels were altered in both mg54 and mu86 mutants, as well as in three different long-
lived backgrounds, 47 genes were identified that correlate with longevity in C. elegans.    
In these 47 genes are multiple "gold-standard" DAF-16/FoxO targets involved in lifespan, such 
as sod-3, mtl-1, and dod-3 are present.  The list also includes several novel potential target genes, 
but most importantly, it provides a practical prioritization for evaluating each gene's functional 
role in lifespan.  To begin to test these functional roles, we set up pilot lifespan assays using 
RNAi targeted for many of the 47 putative genes with glp-1 animals.   Of these, the poorly 
characterized gene, Y39G8B.7 is of interest because of its up-regulation in both the glp-1 and 
daf-2 backgrounds and subsequent down-regulation with the addition of mg54 or mu86 (Table 
1).  Additionally, the pilot lifespan data suggested a significant reduction in lifespan using 
Y39G8B.7 RNAi  in the glp-1 background (Fig. 1).  Y39G8B.7 is relatively small protein (179aa) 
with no obvious conservation.  It contains a signal peptide domain and an ShK toxin domain and 
has been identified in previous microarray studies.  However, its functional role in lifespan has 
yet to be tested.  In order to further characterize Y39G8B.7, I validated its role as a target gene 
using qPCR and evaluated its affect on lifespan extension and dauer formation in a more 
rigorous fashion.  Experiments were performed using Y39G8B.7 RNAi, as there is not null 
mutant currently available.     
    
 
 
 
 
Table 1: RNA-seq expression level comparisons for WT, daf-2(e1370), daf-16(mg54);daf-2(e1370), daf-
16(mu86);daf-2(e1370), daf-2(e1368), daf-16(mg54);daf-2(e1368), daf-16(mu86);daf-2(e1368), glp-1, daf-
16(mg54);glp-1, and daf-16(mu86);glp-1  
    
 Figure 1: survival curves for glp-1 animals grown on daf-16 RNAi, Y39G8B.7 RNAi, and vector.  
 Y39G8B.7 RNAi causes statistically significant (p=0.05) reduction in lifespan   
 
RNA source comparison 
Y39G8B.7 expression 
change 
WT vs. daf-2(e1370) 79.1924 
daf-2(e1370) vs. daf-16(mg54);daf-2(e1370) 0.0073 
daf-2(e1370) vs. daf-16(mu86);daf-2(e1370) 0.0115 
WT vs. daf-2(e1368) 4.2188 
daf-2(e1368) vs. daf-16(mg54);daf-2(e1368) 0.1346 
daf-2(e1368) vs. daf-16(mu86);daf-2(e1368) 0.0654 
glp-1 vs. daf-16(mg54);glp-1 0.3904 
glp-1 vs. daf-16(mu86);glp-1 0.3329 
 Materials and Methods 
 Strains and Reagents  
The following strains were used: N2 Bristol (wild-type), daf-2(e1370 (Kimura, 1997)), daf-
16(mg54)(Ogg et al., 1997) , daf-16(mu86)(Lin, Hsin, Libina, & Kenyon, 2001) , daf-2(e1368) 
(Hsin & Kenyon, 1999), and glp-1(e2141)(Priess, Schnabel, & Schnabel, 1987).   
Double mutants were generated using standard genetic crossing techniques.  Animals were 
grown and maintained in Percival I-30NL or I-36NL incubators (Percival Scientific, Inc., Perry, 
IA, USA)  
 
Quantitative Real-Time PCR (qPCR) 
RNA was extracted from 5 cohorts of young-adult animals for each strain as described in (Chen, 
Guo, Dumas, Ashrafi, & Hu, 2013).  cDNA was synthesized using Superscript III Reverse 
Transcriptase kit (Invitrogen) and SYBR Green (Applied Biosystems, Warrington, UK) Real-
Time PCR was performed using primers for sod-3, Y39G8B.7, and act-1 as an internal control.  
Paired one-tailed t tests were performed using Excel.   
RNAi  
Frozen glycerol stocks of HT115 E. coli expressing dsRNA from an L4440 vector were obtained 
from the Ahringer Library (Source BioScience LifeSciences) and spread onto standard culture 
plates containing ampicillin and tetracycline. L4440 vector alone was used as a negative control. 
Individual colonies were grown in HT115 overnight culture with 50ug/mL of ampicillin.  
Lifespan Assays 
Lifespan assays were performed at 20C.  For glp-1 animals, NGM + 5 mM IPTG + 25 mg/ml 
carbenicillin plates were seeded with HT115 containing empty vector or the corresponding RNAi 
clone from overnight culture. dsRNA production was induced overnight by IPTG. Synchronized 
Day 2 adult animals were added and assayed for viability every 1-2 days.  The same procedure 
was followed for daf-2 mutant animals, however, the NGM plates also included 25 lg/mL (100 
lM) 5-fluoro-2′-deoxyuri- dine (FUDR; Sigma-Aldrich, St. Louis, MO, USA).  n = 105 for 
Y39G8B.7 and vector; n = 60 for daf-16.       
Dauer Assays 
Dauer assays were performed at 25C as previously described (Hu, Xu, & Ruvkun, 2006).  NGM 
+ 5 mM IPTG + 25 mg/ml carbenicillin plates were seeded with 250uL of overnight culture 
containing HT115 transfected with empty vector or the designated RNAi clone.  A synchronized 
3-5 hour egglay was performed at 20C, then the animals were removed.  Animals grew at 25C 
on the RNAi, then were assayed for the dauer phenotype at ~48-60 hours.   
 
Results 
Y39G8B.7 expression levels are elevated in daf-2 mutants and diminished by subsequent 
daf-16 mutation  
Both reduced IIS and germline ablation extend lifespan in a DAF-16/FoxO dependent manner in 
C.elegans (Hsin & Kenyon, 1999; Kenyon, 1993; Murakami & Johnson, 1996). We utilized two 
mutant alleles of daf-2/InsR (e1368 and e1370) and the germline ablation mutant, glp-1 in order 
to identify daf-16/FoxO target genes that may be involved in multiple contexts of lifespan 
extension.  As the RNA-seq results in Table 1 show, Y39G8B.7 expression levels were 
upregulated in both long-lived daf-2(e1368 and e1370) backgrounds and downregulated upon 
addition of either daf-16(mg54 or mu86) mutation to these and the glp-1 background.  These 
expression patterns are consistent with a daf-16 target gene with a potential role in lifespan 
extension.  In order to validate Y39G8B.7 as a daf-16 target gene, I performed quantitative real-
time PCR (qPCR) in the same genetic backgrounds and compared the expression changes in the 
same manner as in Table 1.  
Compared to its expression levels in N2, Y39G8B.7 was upregulated in both mutant daf-2 
backgrounds.  The magnitude of increase in daf-2(e1368) was marginally significant (p=0.1), 
while the increase in daf-2(e1370) was statistically significant (p=0.03) (Fig. 2, Table 2).  These 
increases in Y39G8B.7 expression were drastically reduced by the subsequent deletion of daf-
16/FoxO by either mutant allele (Fig. 2).  Again, the magnitude of reduction was marginally 
significant for both daf-16 alleles in daf-2(e1368) and statistically significant for both alleles in 
daf-2(e1370).  The expression changes for all seven genetic backgrounds are similar to those 
observed by RNA-seq.  Furthermore, they mirror the expression trends of a known daf-16/FoxO 
target gene that plays a role in longevity, sod-3 (Fig. 3).  Therefore, the expression data by qPCR 
further validates Y39G8B.7 as a daf-16/FoxO target gene with a potential role in lifespan 
extension.             
 
Figure 2: Relative expression of Y39G8B.7 by qPCR.  e1368 and e1370 are mutant alleles of daf-2/InsR.  mu86 and 
mg54 are mutant alleles of daf-16/FoxO.    The data shown is an average of three biological replicates; the error bars 
denote biological standard deviation.      
 
 
Genetic Background Comparison  p value  
WT vs daf-2(e1370) 0.03353438 
daf-2(e1370) vs. daf-16(mg54);daf-2(e1370) 0.033172899 
daf-2(e1370) vs. daf-16(mu86);daf-2(e1370) 0.032901018 
WT vs daf-2(e1368) 0.100704638 
daf-2(e1368) vs. daf-16(mg54);daf-2(e1368) 0.080152938 
daf-2(e1368) vs. daf-16(mu86);daf-2(e1368) 0.089747302 
Table 2: paired one-tail T-test analysis of genetic background comparisons. 
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 Figure 3: Relative expression of sod-3, a validated daf-16/FoxO target gene that plays a role in lifespan.   
 
Functional Characterization 
Effects of Y39G8B.7 RNAi on lifespan 
As previously mentioned, both reduced IIS and germline ablation extend lifespan in a DAF-
16/FoxO dependent manner in C.elegans (Hsin & Kenyon, 1999; Kenyon, 1993; Murakami & 
Johnson, 1996).  Validated daf-16/FoxO target genes such as sod-3 and mtl-1 have also been 
shown to reduce daf-2 mediated lifespan extension through RNAi (Murphy et al., 2003).  
Y39G8B.7 RNAi was shown to reduce lifespan in a statistically significant fashion in our pilot 
lifespan assay (Fig. 1) and has been shown to be a bona fide target gene of daf-16/FoxO.  
Consequently, I evaluated the role of this gene in daf-2 and glp-1 mediated lifespan extension in 
a more rigorous fashion.  As opposed to the 50 animals on vector and Y39G8B.7 RNAi in the 
pilot lifespan, this assay had 105 animals on each and 50 on daf-16 RNAi.   
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While the assays are still ongoing, it is clear that the median percent survival and overall trends 
for Y39G8B.7 RNAi are not the same as were observed in the pilot experiment.  In the glp-1 
background, the median survival for Y39G8B.7 was reached at 36 days, while the median for 
vector was 32.  As determined by Chi-squared log-rank test (p=0.05), the Y39G8B.7 RNAi and 
Vector curves were not significantly different (glp-1: p = 0.1726, daf-2(e1368): p = 0.6177).  The 
results were similar in the daf-2(e1368) background, where the median was 32 days for both 
vector and Y39G8B.7 and the curves were not significantly different.   
 
 
Figure 4: Effect of Y39G8B.7 RNAi on lifespan in both glp-1 and daf-2(e1368) backgrounds.  Both controls acted in 
a manner consistent with previous results.  105 animals were divided onto 7 plates for Y39G8B.7 and vector, while 
60 were spread across 4 plates for daf-16 in both instances.  Scoring of vector and Y39G8B.7 will continue until 
completion.    
 
Effects of Y39G8B.7 RNAi on dauer arrest 
Dauer is a reversible developmental arrest stage that can be induced by stressful environmental 
conditions such as overcrowding, lack of food, or elevated temperature. The decision to enter 
dauer arrest occurs late in larval 1 (L1) stage and causes worms to undergo morphological 
remodeling into a wiry form with a resistant cuticle and a pharynx that does not pump.  
Additionally, the animals cease to exhibit food-seeking behavior and their metabolism is 
drastically slowed (Hu, 2007).  DAF-16/FoxO promotes dauer in daf-2/InsR mutants with 
reduced IIS (Gottlieb & Ruvkun, 1994; Vowels & Thomas, 1992).  Therefore, I hypothesized 
that Y39G8B.7 may influence this phenotype in its capacity as a daf-16/FoxO target gene.   
Although no null mutant is available for Y39G8B.7, I was able to use Y39G8B.7 RNAi to 
roughly assess its effect on dauer arrest in the daf-2(e1368) background of reduced IIS.  Both the 
positive (daf-16) and negative (vector) control behaved as expected and Y39G8B.7 RNAi did not 
appear to have a noticeable effect on dauer arrest in either direction (Fig. 4).          
 
Figure 5: effect of Y39G8B.7 RNAi on dauer arrest in daf-2(e1368) background.  Error bars denote standard 
deviation.   
 
Discussion  
FoxO transcription factors and the IIS pathway that regulates them are conserved in many 
species, where they promote metabolic homeostasis, stress resistance, and longevity (Accili, 
2004; Arden, 2008).  Despite a large body of research on FoxOs, relatively little is known about 
the group of FoxO target genes that play a functional role in the intriguing lifespan extension 
phenotype observed in worms and flies - a phenotype which is likely to be observed in 
0% 
25% 
50% 
75% 
100% 
Vector daf-16 Y39G8B.7 
vertebrates as well.  C. elegans is a useful model organism for approaching this problem, as it 
has only one ortholog of FoxO, DAF-16 and a short lifespan.  Our lab's unique genetic filers that 
we employed allowed us to identify genes whose expression levels are altered in three different 
long-lived backgrounds as well as by specific deletion of the DAF-16/FoxO isoforms that play a 
role in longevity.  As a member of this list of 44 putative daf-16/FoxO target genes and due to 
preliminary lifespan data, Y39G8B.7 is a promising potential modulator of lifespan.  While there 
does not appear to be any obvious conservation of the protein in vertebrates, this may be due to 
its small size (179aa) which can make it very difficult to identify homologs using BLAST.    
qPCR validation of Y39G8B.7 expression levels in several long-lived backgrounds confirmed 
this gene is indeed upregulated in these strains and a single additional mutation in daf-16/FoxO 
could significantly reduce this upregulation (Fig. 2).  This information, in combination with our 
previous RNA-seq data, corroborate Y39G8B.7's status as a daf-16/FoxO target gene.   
Unlike so called "gold standard" daf-16/FoxO target genes that are involved in lifespan, 
Y39G8B.7 RNAi demonstrated very little phenotypic effect.  Two of these "gold standard" genes, 
sod-3 and mtl-1 have been shown to suppress lifespan in the daf-2/InsR mutant background by 
RNAi alone (Murphy et al., 2003).  The first pilot replicate of Y39G8B.7 RNAi lifespan showed 
significant suppression (Fig. 1), but the more robust second assay did not show any effect (Fig. 
4).  This disparity may be due to differential knockdown by RNAi in the two experiments, or the 
emergence of the true phenotypic effect with a larger sample size.  Incomplete RNAi knockdown 
is also a possible explanation for a lack of a differential dauer phenotype.  This shortcoming can 
only be truly overcome using a full knockout, but a second dauer assay in which the parental 
generation is raised on RNAi as well is under way.  This should serve to maximize RNAi 
exposure time and to eliminate the possibility of maternal rescue.  It is assumed that the target 
genes are acting in the intestines, where DAF-16/FoxO exerts its effects, but it is also possible 
that Y39G8B.7 functions in an RNAi-resistant tissue and this is affecting phenotypic outputs. 
There are numerous shortcomings and caveats of using RNAi knockdown, and obtaining a null 
mutant from the National Bioresource Project (http://www.shigen.nig.ac.jp/c.elegans/) would 
help to address these.     
Other than the unavoidable possibility of incomplete knockdown by RNAi, there are two other 
reasons that no phenotypic effect was observed in lifespan or dauer assays.  The first is that 
Y39G8B.7 simply is not involved in lifespan control.  This is a possibility that is hard to test 
without a full knockout, but one that was hopefully avoided through our vetting system of 
multiple genetic filters for daf-16/FoxO targets involved in longevity.  The second, more likely 
possibility is that Y39G8B.7 is involved in a more complex system that affects lifespan.  In order 
to investigate the possibility of functional redundancy, I compared our list of 47 putative target 
genes with the list of Y39G8B.7 paralogs without finding any matches.   
Y39G8B.7 contains two functional domains, Signal Peptide (SP), and ShK (metridin-like ShK 
toxin), that may play a role in its function.  The presence of a SP domain means that Y39G8B.7 
enters the secretory pathway and may be secreted, allowing for the possibility of cell-
nonautonomous expression of the protein.  The ShK toxin domain is found in metridin, a toxin 
produced from a type of sea anemone, where it serves as a potent inhibitor of potassium channels 
(Pennington et al., 1999).  Some C. elegans proteins that contain the ShK toxin domain are 
candidate secreted antimicrobials that have been reported to be under the control of PMK-1, 
which encodes a mitogen-activated protein kinase (MAPK) that plays a critical role in the PMK-
1 p38 MAPK pathway (Troemel et al., 2006).  This pathway and the IIS pathway have been 
shown to control intestinal innate immunity (Garsin et al., n.d.; Dennis H Kim et al., 2002).  
Y39G8B.7 fits the description of these ShK toxin-like secreted antimicrobials and is even co-
expressed with three of the ShK toxin candidates identified by Troemel, et. al. - F01D5.1, 
F01D5.2, and F01D5.5 (co-expression analysis by SPELL - (Hibbs et al., 2007)).  However, 
Y39G8B.7 does not fit the model proposed by Troemel, et. al. (Fig. 6).  This model shows PMK-
1 upregulating ShK toxin-like candidate antimicrobials, and DAF-16/FoxO inhibiting their 
expression.  If Y39G8B.7 is truly a secreted antimicrobial, either DAF-16/FoxO upregulates 
expression of some ShK toxin-like genes independently of PMK-1, or some ShK toxin-like 
genes are regulated by both PMK-1 and DAF-16/FoxO.  Either way, this would elevate the role 
of DAF-16/FoxO in direct innate immunity and provide an indirect method by which Y39G8B.7 
could modulate lifespan through innate immunity. 
 Innate immunity's role in lifespan extension is not well understood.   However, multiple DAF-
16/FoxO target genes implicated in longevity have also been identified as secreted antimicrobials 
(Murphy et al., 2003; Troemel et al., 2006).  Additionally, PMK-1 has been shown to contribute 
to lifespan extension in the daf-2 background (Troemel et al., 2006).  The potential role of innate 
immunity in longevity is furthered by the fact that aged animals have been shown to have 
extensive intestinal proliferation of E. coli and that nematodes grown on dead bacteria live 
longer than those grown on live bacteria (Garigan et al., 2002; Gems & Riddle, 1996).  
Consequently, innate immunity may be the complex system by which  Y39G8B.7, which has 
been validated as a bona fide daf-16/FoxO target gene, exerts its effects on lifespan extension.   
   
 Figure 6: Model for Regulation of Immunity/Longevity by the PMK-1 p38 MAPK Pathway and the DAF-2, DAF-
16 Insulin-Signaling Pathway in C. elegans(Troemel et al., 2006) 
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